tiagabine has been researched along with sertraline in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Connor, KM; Davidson, JR; Foa, EB; Hertzberg, MA; Payne, VM; Rothbaum, BO; Weisler, RH | 1 |
Berger, P; Bloch, DA; Coleman, FS; Elkashef, A; Goldsmith, RJ; Harrer, JM; Leiderman, DB; Mezinskis, JP; Montgomery, MA; Singal, BM; Somoza, EC; Winhusen, TM | 1 |
1 review(s) available for tiagabine and sertraline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for tiagabine and sertraline
Article | Year |
---|---|
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder.
Topics: Adaptation, Psychological; Adult; Cognitive Behavioral Therapy; Female; Fluoxetine; GABA Agonists; Humans; Male; Middle Aged; Nipecotic Acids; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Tiagabine; Treatment Outcome | 2005 |
A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.
Topics: Adult; Anticonvulsants; Cocaine-Related Disorders; Donepezil; Female; Humans; Indans; Male; Middle Aged; Nipecotic Acids; Piperidines; Selective Serotonin Reuptake Inhibitors; Sertraline; Tiagabine | 2005 |
2 other study(ies) available for tiagabine and sertraline
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |